Trial Profile
Effect of Intranasal Oxytocin on Social Cognition
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Body dysmorphic disorder; Obsessive-compulsive disorders
- Focus Therapeutic Use
- 23 Jan 2018 Status changed from recruiting to completed.
- 27 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Jul 2017.
- 27 Apr 2017 Planned primary completion date changed from 1 Jun 2016 to 1 Jul 2017.